Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Gynecologic Oncology
|
March 21, 2012
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer
C H Kim, N R Abu-Rustum, D S Chi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 13, 2008
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology
D S Chi, R R Barakat, M J Palayekar, et al.
Gynecologic Oncology
|
December 15, 2010
Risk factors for recurrence of ovarian borderline tumors
K K Shih, Q Zhou, J Huh, et al.
Gynecologic Oncology
|
May 23, 2006
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, et al.
Gynecologic Oncology
|
December 27, 2008
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy
O Zivanovic, M M Leitao, K J Park, et al.
Gynecologic Oncology
|
January 17, 2013
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer
M M Leitao, F Khoury-Collado, G Gardner, et al.
Gynecologic Oncology
|
December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care
N R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology
|
May 17, 2011
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes
F Khoury-Collado, M P Murray, M L Hensley, et al.
Gynecologic Oncology
|
May 16, 2013
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?
J N Barlin, K C Long, E J Tanner, et al.
Gynecologic Oncology
|
October 30, 2021
Increasing global accessibility to high-level treatments for cervical cancers
C Chargari, M Arbyn, A Leary, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Gynecologic Oncology
|
March 21, 2012
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer
C H Kim, N R Abu-Rustum, D S Chi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 13, 2008
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology
D S Chi, R R Barakat, M J Palayekar, et al.
Gynecologic Oncology
|
December 15, 2010
Risk factors for recurrence of ovarian borderline tumors
K K Shih, Q Zhou, J Huh, et al.
Gynecologic Oncology
|
May 23, 2006
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, et al.
Gynecologic Oncology
|
December 27, 2008
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy
O Zivanovic, M M Leitao, K J Park, et al.
Gynecologic Oncology
|
January 17, 2013
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer
M M Leitao, F Khoury-Collado, G Gardner, et al.
Gynecologic Oncology
|
December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care
N R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology
|
May 17, 2011
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes
F Khoury-Collado, M P Murray, M L Hensley, et al.
Gynecologic Oncology
|
May 16, 2013
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?
J N Barlin, K C Long, E J Tanner, et al.
Gynecologic Oncology
|
October 30, 2021
Increasing global accessibility to high-level treatments for cervical cancers
C Chargari, M Arbyn, A Leary, et al.
Page
of 5